New injection aims to tame heavy periods
NCT ID NCT07169214
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests an injectable drug called BT-114143 in 39 women with abnormal uterine bleeding. Participants receive different doses twice daily for three days to see if it safely reduces bleeding. The study also checks for side effects and changes in blood clotting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BT-114143 injection
- What this could lead to
- If it works, this could provide a new treatment option to reduce heavy menstrual bleeding.
- What could go wrong
- This is an early Phase 1 trial with only 39 participants, so safety and effectiveness are not yet proven. The drug may not work or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABNORMAL UTERINE BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can watching videos before surgery calm nerves?
- New tool could sharpen hysteroscopy training
- New stitch could speed up hysterectomy surgery
- New handmade IUD aims to stay put in women with adenomyosis
- Could a deep breath replace a clamp? new study tests Pain-Free biopsy
- Which womb biopsy method works best? new study compares two common techniques